AstraZeneca sees pivotal lung cancer trial results later in 2018

LONDON (Reuters) - AstraZeneca now expects a key lung cancer study of two immunotherapy drugs to produce overall survival results in the second half of 2018, rather than the first half.

GSK wins new reprieve as Hikma's generic Advair delayed again

(Reuters) - GlaxoSmithKline has won a further reprieve for its blockbuster Advair lung drug after U.S. regulators insisted Hikma Pharmaceuticals conduct a further clinical study evaluating its generic version of the drug.

How infertility treatment has left sperm science behind

LONDON, (Reuters) – - They can make test-tube babies, grow human eggs in a lab and reproduce mice from frozen testicle tissue, but when it comes to knowing how a man's sperm can swim to, find and fertilize an egg, scientists are still floundering.

South Africa gold miners' silicosis lawsuit settlement expected within six weeks

JOHANNESBURG (Reuters) - South African gold producers will likely reach a settlement within six weeks in a lawsuit over a fatal lung disease that companies have set aside 5 billion rand ($420 million) in provisions for, a lawyer and industry group said on Sunday.

Regeneron/Sanofi heart drug succeeds in major trial; Will insurers pay?

(Reuters) - A potent, expensive cholesterol drug sold by Regeneron Pharmaceuticals and Sanofi significantly reduced major adverse heart events in a huge study presented on Saturday but it remains to be seen whether the new data will prompt insurers to pay for increased use of the medicine.

South African rights lawyer plans listeria class action against Tiger Brands

JOHANNESBURG (Reuters) - A human rights lawyer plans to launch a class action lawsuit against South African food producer Tiger Brands on behalf of the families of people who died and those affected by the worst listeria outbreak in history.

Two million children in Congo at risk of starvation, U.N. warns

GENEVA (Reuters) - More than 2 million children in the Democratic Republic of Congo are estimated to be at risk of dying from severe acute malnutrition if they do not get the aid they need, the United Nations warned on Friday.

Common knee surgery doesn’t help older adults

(Reuters Health) – Many older adults are getting surgery to remove damaged cartilage in the knee even though these operations may not help ease pain or improve mobility in people over 65, a U.S. study suggests.

Some women with asthma may struggle to conceive

(Reuters Health) - Women with asthma who use short-acting inhalers to control symptoms may take longer to conceive than women without asthma, a recent study suggests.

Decline in living kidney donors led by men

(Reuters Health) - The number of kidney transplants using organs from living donors has declined in the U.S. since 2005, and only high-income women are becoming kidney donors at a greater rate than they were more than a decade ago, the authors of a new study have found.

Related Videos

Whalecam reveals secrets of Antarctic minke

Hybrid bee at the heart of UAE sustainable honey plan

Read Reuters on the go

Download the free Reuters News app today for breaking news, analysis and market data from the world's most trusted news organization.

Get the app